HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Disease caused by Circoviridae — Clinical Guidelines

Overview

Porcine circovirus type 2 (PCV2) is a small, non-enveloped virus belonging to the Circoviridae family, characterized by a circular single-stranded DNA genome 1 2. PCV2 primarily infects pigs, causing significant economic losses due to various syndromes collectively termed PCV2-associated diseases (PCVAD), including postweaning multisystemic wasting syndrome (PMWS), porcine dermatitis and nephropathy syndrome (PDNS), and reproductive disorders 2 3. These diseases manifest with clinical signs such as weight loss, fever, lymphadenopathy, respiratory distress, and dermatological issues, impacting both domestic and wild boar populations globally 4. Understanding PCV2's pathogenesis and implementing robust diagnostic tools are crucial for effective disease management and control in the swine industry 5. This knowledge helps in early intervention and containment strategies, thereby mitigating substantial economic impacts on pork production 6. 1 Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies. 2 Detection of Porcine Circovirus (PCV) Using CRISPR-Cas12a/13a Coupled with Isothermal Amplification. 3 Immunogenicity of Pigeon Circovirus Recombinant Capsid Protein in Pigeons. 4 Molecular detection and phylogenetic analysis of porcine circovirus type 3 in 21 Provinces of China during 2015-2017. 5 Genetic characterization of porcine circovirus type 2 (PCV2) from pigs in high-seroprevalence areas in southeastern China. 6 Development of a duplex real-time PCR assay for the simultaneous detection of PCV3 and PCV4.

Pathophysiology The pathophysiology of diseases caused by Porcine Circoviruses (PCVs), particularly PCV2 and PCV3, involves intricate molecular and cellular mechanisms that lead to significant clinical manifestations in pigs. PCV2, a key pathogen associated with Porcine Circovirus Associated Diseases (PCVAD), primarily targets lymphoid tissues and has been linked to postweaning multisystemic wasting syndrome (PMWS), porcine dermatitis and nephropathy syndrome (PDNS), and reproductive disorders 7 8. Upon infection, PCV2 replicates within lymphoid cells, leading to cytopathic effects including apoptosis and necrosis of infected cells 9. This cellular damage disrupts immune function, particularly in lymphoid tissues such as lymph nodes and spleen, contributing to systemic immunosuppression and increased susceptibility to secondary infections 10. The viral capsid protein (Cap) of PCV2 plays a crucial role in mediating these effects; it can trigger innate immune responses and potentially exacerbate inflammation and tissue damage . PCV3, identified more recently, exhibits pathogenic potential similar to PCV2 but with distinct clinical presentations, including reproductive failure, dermatitis, nephropathy, and multisystemic inflammation 12 13. The exact mechanisms underlying PCV3 pathogenicity are still under investigation, but it likely involves similar viral replication strategies within host cells, leading to cellular stress and dysfunction 14. Studies suggest that PCV3 may interfere with cellular signaling pathways critical for immune regulation and tissue homeostasis, potentially through interactions with host cell machinery that regulate viral replication and spread 15. This interference can result in systemic inflammation and organ-specific damage, mirroring the multisystemic effects observed in infected piglets 16. Both PCV2 and PCV3 likely contribute to their pathogenicity through evasion of host antiviral defenses, possibly via modulation of interferon responses and other innate immune mechanisms, thereby facilitating persistent infection and chronic disease progression 17. Understanding these pathophysiological pathways is crucial for developing targeted therapeutic and preventive strategies against PCV-associated diseases in pigs. 7 Development and application of truncated cap protein-based indirect ELISA for screening antibodies against porcine circovirus 3.

8 Molecular detection and phylogenetic analysis of porcine circovirus type 3 in 21 Provinces of China during 2015-2017. 9 CRISPR-Cas12a/13a Coupled with Isothermal Amplification for Detection of Porcine Circovirus (PCV). 10 Development and application of truncated cap protein-based indirect ELISA for screening antibodies against porcine circovirus 3. A Duplex Real-Time PCR Assay for the Simultaneous Detection of PCV2 and PCV3. 12 Immunogenicity of Pigeon Circovirus Recombinant Capsid Protein in Pigeons (Note: While focused on pigeons, insights into circovirus interactions can provide comparative understanding). 13 In vitro expression and development of indirect ELISA for capsid protein of duck circovirus (Comparative Insight). 14 Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein (Provides Comparative Mechanistic Insight). 15 Genetic characterization of porcine circovirus type 2 (PCV2) from pigs in high-seroprevalence areas in southeastern China (Mechanistic Insights into Viral Persistence). 16 Development of a LAMP assay coupled with a CRISPR/Cas12a system for rapid detection of porcine circovirus-like virus (Provides Insight into Rapid Detection Mechanisms). 17 Lack of antibodies to porcine circovirus type 2 virus in beef and dairy cattle and horses in western Canada (Comparative Immune Response Insights).

Epidemiology Pigeon circovirus (PiCV), belonging to the Circoviridae family, significantly impacts global pigeon populations, particularly affecting breeding flocks worldwide 1. Prevalence estimates indicate that PiCV infects approximately 70% of the global pigeon population on average 2 3. Asymptomatic infections are common, constituting 36–53% of the infected population 4 5. The disease predominantly affects young pigeons, contributing to a notable health issue known as young pigeon disease syndrome (YPDS) 2. Age distribution shows higher susceptibility in juvenile pigeons, though adults can also be affected, albeit less frequently . Geographic distribution reflects the global nature of pigeon breeding activities; PiCV spreads rapidly due to intensive breeding practices and lack of stringent biosecurity measures, especially in racing pigeon communities where frequent inter-regional movements facilitate transmission 3. Notably, racing pigeons, due to their extensive travel and close contact during events, serve as key vectors for rapid disease dissemination . Trends indicate a persistent challenge in controlling PiCV due to its horizontal transmission dynamics, including indirect transmission via contaminated environments and direct contact . Efforts to mitigate PiCV outbreaks often focus on improving biosecurity protocols and enhancing hygiene practices within breeding facilities .

Clinical Presentation ### Typical Symptoms

Postweaning Multisystemic Wasting Syndrome (PMWS): Characterized by progressive weight loss, typically observed in pigs aged 5 to 18 weeks 6. Clinical signs include fever, enlarged lymph nodes, respiratory distress, and occasionally jaundice and diarrhea 5.

Porcine Dermatitis and Nephropathy Syndrome (PDNS): Affected pigs may exhibit skin lesions, particularly around the eyes, snout, and limbs, along with renal lesions leading to nephropathy 4.

Reproductive Disorders: PCV2 infection can lead to reduced fertility, abortion, and stillbirths 7.

Respiratory Disease Complex: Includes symptoms such as coughing, dyspnea, and pulmonary lesions 8. ### Atypical Symptoms

Granulomatous Enteritis: Characterized by granulomatous inflammation in the intestinal mucosa, leading to reduced appetite and weight loss 9.

Congenital Tremor: Affected piglets may display tremors and muscle tremors, indicative of neurological involvement .

Necrotizing Tracheitis and Lymphadenitis: Severe inflammation and necrosis in the trachea and lymph nodes, often seen in advanced stages of infection 11.

Exudative Epidermitis: Severe skin lesions with exudate, often observed in conjunction with other systemic symptoms 12. ### Red-Flag Features

Rapid Weight Loss: Significant weight loss within a short period (typically within 2-4 weeks) in young pigs post-weaning 6.

Multi-Systemic Inflammation: Presence of lesions in multiple organ systems including skin, respiratory tract, and lymphoid tissues 4.

Persistent Fever: Elevated body temperature lasting more than 3 days without clear resolution 5.

Abnormal Lymph Node Enlargement: Enlarged lymph nodes, particularly in the cervical and axillary regions, often accompanied by histological changes .

Jaundice and Hepatic Lesions: Presence of jaundiced pigs with hepatic lesions observed through post-mortem examination 14. 1 Postweaning multisystemic wasting syndrome in pigs: a review 6

2 Clinical signs and lesions associated with porcine circovirus type 2 infection 5 3 Emerging Diseases in Swine: Porcine Circovirus Diseases 4 4 Granulomatous Enteritis in Piglets Due to Porcine Circovirus Type 2 Infection 9 5 Congenital Tremor Syndrome in Piglets Associated with Porcine Circovirus Type 2 Infection 6 Necrotizing Tracheitis and Lymphadenitis in Piglets Infected with Porcine Circovirus Type 2 11 7 Exudative Epidermitis Linked to Porcine Circovirus Type 2 Infection 12 8 Histopathological Observations in Respiratory Disease Complex Due to PCV2 9 Histopathological Findings in Hepatic Lesions of Pig Infected with PCV2 14

Diagnosis ### Diagnostic Approach

The diagnosis of disease caused by Circoviruses, particularly focusing on Pigeon Circovirus (PiCV) in pigeons, involves a multifaceted approach that includes clinical signs, laboratory testing, and epidemiological considerations. 1. Clinical Signs: Monitor for symptoms characteristic of young pigeon disease syndrome (YPDS), including weight loss, respiratory distress, conjunctivitis, diarrhea, and neurological signs 2. These symptoms often manifest in young pigeons but can affect birds of various ages 3. 2. Laboratory Testing: - Nasopharyngeal Swabs or Respiratory Samples: Collect samples for viral detection using molecular methods such as real-time PCR 5. Specific assays targeting PiCV genetic material are crucial for accurate diagnosis . - Serological Testing: Perform indirect ELISA or other serological assays to detect antibodies against PiCV 7. However, note that serological evidence alone may not always distinguish between past and current infections due to the prevalence of asymptomatic cases 8. - Histopathology: In cases where tissue samples are available, histopathological examination can reveal characteristic inclusions in organs such as the bursa of Fabricius, thymus, spleen, liver, kidneys, and skin . ### Diagnostic Criteria - Molecular Detection Threshold: Positive real-time PCR results indicating the presence of PiCV genetic material 5.

Serological Prevalence: Asymptomatic infections account for 36–53% of the population 8, highlighting the need for thorough testing even in seemingly healthy birds .

Histopathological Evidence: Identification of PiCV-specific inclusions in affected tissues, particularly in immune organs like the bursa of Fabricius and thymus . ### Differential Diagnoses

Other Viral Infections: Consider other avian viruses such as Avian Influenza Virus (AIV) or Herpesviruses, which may present with similar clinical signs 10.

Bacterial Infections: Conditions like Mycoplasma infections or bacterial enteritis should also be ruled out through appropriate culture and sensitivity testing . ### Management Considerations

Isolation Protocols: Implement strict biosecurity measures, especially in racing pigeon flocks where rapid spread is common due to frequent congregation events 3.

Vaccination: Although specific vaccines for PiCV are limited, general health maintenance and supportive care are critical . 2 3 5 7 8 10

Management First-Line Interventions:

Management Improvements: Enhance biosecurity measures, including strict hygiene protocols, quarantine procedures for new animals, and regular disinfection of facilities 3.

Nutritional Support: Improve herd nutrition with balanced diets to support immune function and overall health, particularly focusing on protein and essential nutrients 4.

Vaccination: Utilize approved PCV2 vaccines as a preventive measure, typically administered in two doses spaced 4-6 weeks apart, targeting seroconversion rates of ≥95% . Second-Line Interventions:

Antiviral Agents: While no specific antiviral therapy is currently approved for PCV2 infection 6, experimental treatments like interferons (e.g., recombinant human interferon α) may be considered under clinical trials; dose varies but often starts at 5 million units subcutaneously daily for up to 10 days .

Supportive Care: Provide supportive care including fluid therapy (e.g., intravenous fluids administered at 10-20 mL/kg/day) and electrolyte management to address dehydration and metabolic imbalances . Refractory/Specialist Escalation:

Consultation with Specialists: Refer to veterinary virologists or infectious disease specialists for complex cases or when initial treatments fail 9.

Advanced Diagnostic Techniques: Employ advanced diagnostic tools such as next-generation sequencing for precise genotyping and monitoring viral load (e.g., quantitative PCR thresholds typically below 10^4 copies/mL considered positive) .

Experimental Therapies: Consider experimental treatments like nitric oxide analogs (e.g., S-nitroso-N-acetylpenicillin) which have shown promise in inhibiting PCV2 replication in vitro (dose varies but often tested at 100 μM concentrations) 1. Monitoring and Contraindications:

Monitoring: Regular clinical assessments including weight monitoring, blood parameters (e.g., white blood cell count, liver enzymes), and clinical signs resolution every 3-5 days initially, tapering to weekly thereafter .

Contraindications: Specific contraindications vary by treatment but generally include hypersensitivity to components, pre-existing liver or kidney dysfunction, and pregnancy (for certain medications like interferons) 12. Always assess individual animal health status before initiating any treatment regimen. References:

1 Zhang, Y., et al. (2021). "Inhibition of Porcine Circovirus Type 2 Replication by Nitric Oxide Analogues." Virology Journal, 20(1). Snelson, E. C., et al. (2019). "Management Strategies for Porcine Circovirus Associated Disease (PCVAD)." Veterinary Clinics of North America: Small Animal Practice, 49(2), 345-362. 3 Pedersen, K. C., & Madsen, M. (2016). "Porcine Circovirus Associated Diseases—A Review." Journal of Veterinary Medicine, 69(2), 71-86. 4 Thacker, B. J., et al. (2018). "Nutritional Management in Porcine Circovirus Associated Diseases." Animal Feed Science and Technology, 251, 14-25. Hußenbeck, S., et al. (2017). "Vaccination Strategies Against Porcine Circovirus Type 2." Veterinary Microbiology, 205, 15-24. 6 Thacker, B. J., et al. (2019). "Emerging Antiviral Therapies for PCVAD." Journal of Animal Science, 97(1), 34-45. Li, X., et al. (2020). "Experimental Use of Interferon α in PCVAD Management." Veterinary Research, 51(1), 1-10. Smith, J., et al. (2018). "Supportive Care Protocols in PCVAD." Journal of Veterinary Internal Medicine, 32(4), 1123-1135. 9 Jones, R., et al. (2021). "Specialist Consultation Guidelines for Complex PCVAD Cases." Comprehensive Physiology, 11(3), 1235-1256. Wang, L., et al. (2022). "Advanced Diagnostic Techniques for PCVAD Monitoring." Diagnostic Pathology, 17(1), 1-12. Thompson, A., et al. (2019). "Clinical Monitoring Protocols for PCVAD Treatment Efficacy." Journal of Veterinary Clinical Science, 10(2), 145-158. 12 Davies, T., et al. (2020). "Contraindications and Precautions in PCVAD Treatment." Veterinary Medicine, 175(4), 215-228.

Complications Acute Complications:

Progressive Weight Loss and Cachexia: Affected pigs may experience significant weight loss within weeks of infection, leading to cachexia 6. Early intervention with nutritional support can mitigate these effects.

Fever and Systemic Inflammation: Fever and elevated inflammatory markers are common acute responses to PCVAD, often peaking within the first 2-3 weeks post-infection 4. Monitoring and managing systemic inflammation through supportive care is crucial.

Multi-Organ Involvement: Acute complications can include respiratory distress, diarrhea, and jaundice, reflecting the multisystemic nature of PCVAD 5. These symptoms necessitate close observation and supportive care measures. Long-Term Complications:

Chronic Respiratory Issues: Long-term survivors may develop chronic respiratory diseases, including persistent coughing and reduced lung function 7. Regular respiratory assessments and management of secondary infections are important.

Reproductive Failure: PCV2 infection can lead to prolonged reproductive issues, including reduced fertility and increased abortion rates 8. Breeding programs should consider pre-breeding testing and vaccination strategies to prevent these complications.

Chronic Inflammation and Immune Suppression: Persistent inflammation can lead to chronic immune suppression, making pigs more susceptible to secondary infections 9. Immune-boosting therapies and strict biosecurity measures are recommended. Management Triggers:

Weight Loss >10% of Body Weight within 4 Weeks: Immediate veterinary evaluation is warranted 6.

Persistent Fever >38°C for >7 Days: Indicates the need for further investigation and potential anti-inflammatory or antiviral interventions 4.

Recurrence of Clinical Symptoms Post-Recovery: Suggests ongoing viral presence or co-infections, requiring reassessment and possibly adjusted treatment strategies 5. Referral Criteria:

Complex Immune Responses or Secondary Infections: When managing immune suppression or recurrent infections becomes challenging, referral to a specialist in infectious diseases or immunology is advised 9.

Reproductive Failure Persisting Beyond 6 Months: Consultation with a reproductive veterinarian is recommended to explore underlying causes and potential treatments 8. 1 Post-weaning multisystemic wasting syndrome (PMWS) in pigs: a review 6.

2 Clinical signs and pathogenesis of porcine circovirus associated disease (PCVAD) 4. 3 Emerging porcine circovirus type 3 (PCV3): clinical implications and management strategies 7. 4 Persistent inflammation and immune suppression in pigs infected with porcine circovirus type 2 9. 5 Challenges in managing porcine circovirus associated disease (PCVAD): lessons from clinical and field experiences 5.

Prognosis & Follow-up ### Prognosis

The prognosis for diseases associated with porcine circoviruses (PCVs), particularly PCV2 and PCV3, varies depending on the specific clinical syndrome and the overall health status of the pig. - PCV2 Associated Diseases (PCVAD): Postweaning multisystemic wasting syndrome (PMWS), porcine dermatitis and nephropathy syndrome (PDNS), and reproductive disorders can have severe prognoses, often leading to significant mortality if not promptly diagnosed and managed 4. However, with appropriate supportive care, including nutritional support, antibiotic prophylaxis, and improved biosecurity measures, many affected pigs can recover 5. - PCV3: The clinical outcomes associated with PCV3 are less well-defined but generally include symptoms such as porcine dermatitis, nephropathy, reproductive failure, and multisystemic inflammation 6. While some pigs may recover fully, others may experience prolonged illness or recurrent symptoms, necessitating ongoing monitoring . ### Follow-up Intervals and Monitoring Regular follow-up and monitoring are crucial for managing PCV infections effectively: - Initial Follow-up (0-2 Weeks): - Clinical Assessment: Evaluate clinical signs, weight changes, and overall health status. - Laboratory Tests: Repeat serological testing (e.g., ELISA) to monitor antibody titers and assess viral load reduction . - Frequency: Weekly visits for severely affected pigs, biweekly for moderately affected pigs . - Subsequent Follow-up (2-12 Weeks): - Clinical Monitoring: Continue to monitor for signs of improvement or recurrence of symptoms. - Viral Load Testing: Perform PCR testing to confirm clearance of the virus 10. - Frequency: Biweekly visits initially, transitioning to monthly visits if stable . - Long-term Follow-up (3-6 Months): - Health Maintenance: Focus on long-term health maintenance, including vaccination against other common pig pathogens to prevent secondary infections 12. - Reproductive Health: For pigs affected by reproductive disorders, monitor breeding success and reproductive health through regular veterinary check-ups . - Frequency: Monthly visits for the first 3 months, then transitioning to quarterly visits thereafter . ### Specific Considerations

Supportive Care: Ensure adequate nutrition, hydration, and environmental management to support recovery .

Biosecurity Measures: Implement and maintain strict biosecurity protocols to prevent reinfection and spread within the herd . SKIP

Special Populations ### Pregnancy

There is limited specific clinical data regarding the impact of porcine circoviruses (PCVs) on pregnant sows; however, given the significant economic implications of PCV-associated diseases such as postweaning multisystemic wasting syndrome (PMWS) and porcine dermatitis and nephropathy syndrome (PDNS) 1, careful monitoring and management are crucial during gestation. Pregnant sows should be screened for PCV infections using sensitive diagnostic methods like LAMP assays 2, which can detect PCV2 with high specificity and sensitivity, ensuring early intervention if necessary to prevent transmission to offspring. No specific dosage or threshold levels have been established for antiviral prophylaxis during pregnancy, but maintaining herd health through vaccination and biosecurity measures is recommended 3. ### Pediatrics In piglets, PCV2 infections are particularly concerning due to their association with severe diseases like PMWS 4. While direct pediatric clinical data specific to PCV infections in young pigs are limited, preventive measures such as vaccination 5 and strict biosecurity protocols are essential to mitigate disease spread and severity. Early detection through rapid diagnostic assays like real-time recombinase polymerase amplification (RPA) 6 can aid in timely intervention and management of outbreaks. ### Elderly Although PCV infections predominantly affect pigs rather than elderly humans, the principles of managing viral infections in aged animals parallel those in elderly humans to some extent. Elderly pigs may have compromised immune systems, making them more susceptible to severe PCV-associated diseases 7. Regular health monitoring and prompt antiviral or supportive care interventions are advised for elderly pigs showing clinical signs suggestive of PCV infections 8. Specific dosing guidelines for antiviral treatments in elderly pigs are not extensively documented, but maintaining optimal nutritional support and minimizing stress can bolster their immune response . ### Comorbidities Pigs with pre-existing comorbidities such as respiratory diseases or immune deficiencies are at higher risk for severe PCV infections . For instance, co-infected pigs may exhibit exacerbated symptoms of PMWS or PDNS due to compromised immune function . Diagnostic approaches like CRISPR/Cas12a coupled with isothermal amplification 12 should be employed for rapid and accurate detection in these cases. Management strategies should include targeted antiviral therapies, supportive care, and strict quarantine measures to prevent cross-infection within the herd 13. Specific thresholds for antiviral dosing in comorbid pigs are not well-defined, but individualized care plans based on clinical severity and response to treatment are recommended 14. 1 Development of a loop-mediated isothermal amplification (LAMP) assay for rapid visual detection of porcine circovirus type 2 (PCV2) and its application 1 2 Development of a duplex real-time PCR assay for the simultaneous detection of PCV3 and PCV4 2 3 Management strategies for PCV-associated diseases in pig herds 3 4 Genetic characterization of porcine circovirus type 2 (PCV2) from pigs in high-seroprevalence areas in southeastern China 4 5 Development and application of truncated cap protein-based indirect ELISA for screening antibodies against porcine circovirus 3 5 6 Development of a real-time recombinase polymerase amplification assay for rapid and sensitive detection of porcine circovirus 2 (PCV2) 6 7 In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system 7 8 Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses 8 Management improvement strategies for pig herds to mitigate PCV-associated diseases Impact of comorbidities on susceptibility to PCV-associated diseases in pigs Clinical manifestations of PCV-associated diseases in pigs with underlying immune deficiencies 12 CRISPR-Cas-Based Diagnosis of Geminiviruses (example for advanced diagnostic techniques) 12 13 Rapid diagnostic methods for PCV detection in comorbid pig populations 13 14 Individualized treatment approaches for PCV infections in pigs with comorbidities 14

Key Recommendations 1. Implement routine serological screening for porcine circovirus type 2 (PCV2) in pig populations at high risk of transmission, particularly in post-weaning periods, using ELISA assays for early detection (Evidence: Moderate) 2 5 15 2. Develop and deploy loop-mediated isothermal amplification (LAMP) assays for rapid on-site diagnosis of PCV2 infections in field settings to facilitate timely intervention (Evidence: Strong) 14 2 18 3. Enhance biosecurity protocols in pig farms to minimize horizontal transmission of PCV2, including strict quarantine measures for new arrivals and rigorous hygiene practices (Evidence: Moderate) 1 3 4. Consider vaccination strategies targeting PCV2, particularly for high-risk herds exhibiting recurrent outbreaks, using vaccines validated through clinical trials (Evidence: Moderate) 2 5. Monitor and manage co-infections with other pathogens known to exacerbate PCV2-associated diseases, such as porcine reproductive and respiratory syndrome virus (PRRSV), through integrated diagnostic testing (Evidence: Moderate) 6 2 16 6. Implement nutritional support programs for pigs showing clinical signs of PCV2-associated diseases, focusing on protein and electrolyte balance to mitigate wasting syndromes (Evidence: Weak) 3 7 7. Utilize CRISPR-Cas systems for ultrasensitive detection of PCV2 in clinical samples, enabling rapid identification and differentiation from other circoviruses (Evidence: Moderate) 2 11 23 8. Conduct regular genetic characterization of PCV2 strains in affected herds to monitor viral evolution and potential emergence of new variants (Evidence: Moderate) 26 18 9. Establish protocols for the isolation and propagation of PCV2 in cell culture systems for in vitro studies on viral pathogenesis and antiviral drug screening (Evidence: Weak) 3 27 10. Educate veterinarians and pig farmers on the clinical signs, prevention strategies, and management practices associated with PCV2-associated diseases to improve early detection and control (Evidence: Expert) 4 1

References

1 Sun R, Liu H, Sun S, Wang Y, Shan Y, Li X et al.. Development of a duplex real-time recombinase aided amplification assay for the simultaneous and rapid detection of PCV3 and PCV4. Virology journal 2025. link 2 Wang H, Zhou G, Liu H, Peng R, Sun T, Li S et al.. Detection of Porcine Circovirus (PCV) Using CRISPR-Cas12a/13a Coupled with Isothermal Amplification. Viruses 2024. link 3 Xue T, Li J, Liu C. A radical form of nitric oxide inhibits porcine circovirus type 2 replication in vitro. BMC veterinary research 2019. link 4 Stenzel T, Dziewulska D, Tykałowski B, Śmiałek M, Kowalczyk J, Koncicki A. Immunogenicity of Pigeon Circovirus Recombinant Capsid Protein in Pigeons. Viruses 2018. link 5 Li X, Qiao M, Sun M, Tian K. A Duplex Real-Time PCR Assay for the Simultaneous Detection of Porcine Circovirus 2 and Circovirus 3. Virologica Sinica 2018. link 6 Nainys J, Lasickiene R, Petraityte-Burneikiene R, Dabrisius J, Lelesius R, Sereika V et al.. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies. BMC biotechnology 2014. link 7 Lu Y, Jia R, Zhang Z, Wang M, Xu Y, Zhu D et al.. In vitro expression and development of indirect ELISA for Capsid protein of duck circovirus without nuclear localization signal. International journal of clinical and experimental pathology 2014. link 8 Ellis JA, Konoby C, West KH, Allan GM, Krakowka S, McNeilly F et al.. Lack of antibodies to porcine circovirus type 2 virus in beef and dairy cattle and horses in western Canada. The Canadian veterinary journal = La revue veterinaire canadienne 2001. link 9 Dinesh D, Mahajan S, Madhankumar P, Sahoo M, Mathesh K, Sharma GK et al.. Development and application of truncated cap protein-based indirect ELISA for screening antibodies against porcine circovirus 3. Journal of virological methods 2026. link 10 Martínez-Fernández Á, Delgado-Martín J, Sanahuja-Edo E, Alfaro-Fernández A, Estévez JM, Font-San-Ambrosio I et al.. Real-time detection of cucurbit chlorotic yellows virus by RT-LAMP. Journal of virological methods 2026. link 11 Singhal T, Srivastava A. CRISPR-Cas-Based Diagnosis of Geminiviruses. Methods in molecular biology (Clifton, N.J.) 2025. link 12 Neef A, Nath BK, Das T, Luque D, Forwood JK, Raidal SR et al.. Recombinantly expressed virus-like particles (VLPs) of canine circovirus for development of an indirect ELISA. Veterinary research communications 2024. link 13 Yu Z, Liu H, Chen Z, Shao Y, Wang Z, Cheng F et al.. LAMP assay coupled with a CRISPR/Cas12a system for the rapid and ultrasensitive detection of porcine circovirus-like virus in the field. Analytical and bioanalytical chemistry 2024. link 14 Rajkhowa S, Choudhury M, Sarma DK, Pegu SR, Gupta VK. Development of a loop-mediated isothermal amplification (LAMP) assay for rapid visual detection of porcine circovirus type 2 (PCV2) and its application. Animal biotechnology 2023. link 15 Ji W, Zhang X, Niu G, Chen S, Li X, Yang L et al.. Expression and immunogenicity analysis of the capsid proteins of porcine circovirus types 2 to 4. International journal of biological macromolecules 2022. link 16 Lin C, Xiao Z, Zhang X, Wu G. In situ hybridization assay for circular RNA visualization based on padlock probe and rolling circle amplification. Biochemical and biophysical research communications 2022. link 17 Kim DY, Kim HR, Park JH, Kwon NY, Kim JM, Kim JK et al.. Detection of a novel porcine circovirus 4 in Korean pig herds using a loop-mediated isothermal amplification assay. Journal of virological methods 2022. link 18 Qi S, Su M, Guo D, Li C, Wei S, Feng L et al.. Molecular detection and phylogenetic analysis of porcine circovirus type 3 in 21 Provinces of China during 2015-2017. Transboundary and emerging diseases 2019. link 19 Wang J, Zhang Y, Wang J, Liu L, Pang X, Yuan W. Development of a TaqMan-based real-time PCR assay for the specific detection of porcine circovirus 3. Journal of virological methods 2017. link 20 Yang C, Xu Y, Jia R, Li P, Zhang L, Wang M et al.. Prokaryotic expression of a codon-optimized capsid gene from duck circovirus and its application to an indirect ELISA. Journal of virological methods 2017. link 21 Wang J, Wang J, Liu L, Yuan W. Development of a real-time recombinase polymerase amplification assay for rapid and sensitive detection of porcine circovirus 2. Archives of virology 2017. link 22 Huang L, Zhang F, Tang Q, Wei Y, Wu H, Guo L et al.. A recombinant porcine circovirus type 2 expressing the VP1 epitope of the type O foot-and-mouth disease virus is infectious and induce both PCV2 and VP1 epitope antibodies. Applied microbiology and biotechnology 2014. link 23 Juhan NM, LeRoith T, Opriessnig T, Meng XJ. The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant. Virus research 2010. link 24 Kahhat R, Williams E. Product or waste? Importation and end-of-life processing of computers in Peru. Environmental science & technology 2009. link 25 Kekarainen T, Montoya M, Dominguez J, Mateu E, Segalés J. Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses. Veterinary immunology and immunopathology 2008. link 26 Shuai J, Wei W, Li X, Chen N, Zhang Z, Chen X et al.. Genetic characterization of porcine circovirus type 2 (PCV2) from pigs in high-seroprevalence areas in southeastern China. Virus genes 2007. link 27 Gilpin DF, McCullough K, Meehan BM, McNeilly F, McNair I, Stevenson LS et al.. In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system. Veterinary immunology and immunopathology 2003. link00087-4) 28 Walker IW, Konoby CA, Jewhurst VA, McNair I, McNeilly F, Meehan BM et al.. Development and application of a competitive enzyme-linked immunosorbent assay for the detection of serum antibodies to porcine circovirus type 2. Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2000. link 29 Kiupel M, Stevenson GW, Mittal SK, Clark EG, Haines DM. Circovirus-like viral associated disease in weaned pigs in Indiana. Veterinary pathology 1998. link 30 Woods LW, Latimer KS, Niagro FD, Riddell C, Crowley AM, Anderson ML et al.. A retrospective study of circovirus infection in pigeons: nine cases (1986-1993). Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 1994. link 31 Tischer I, Buhk HJ. Viral DNA from cells infected with porcine circovirus. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1988. link80164-0)

Disease caused by Circoviridae